The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
申请公布号
SG172022(A1)
申请公布日期
2011.07.28
申请号
SG20110041696
申请日期
2009.12.09
申请人
NOVAVAX, INC.
发明人
PUSHKO, PETER;WU, YINGYUN;MASSARE, MICHAEL;LIU, YE;SMITH, GALE;ZHOU, BIN
